Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer

Anticancer Research

Volumn 35, Issue 3, 2015, Pages 1481-1490

  Onyema, Oscar Okwudiri ^a   Decoster, Lore ^b   Njemini, Rose ^a   Forti, Louis Nuvagah ^a   Bautmans, Ivan ^a   De Waele, Marc ^c   Mets, Tony ^a,d  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Laboratory of Hematology   (Belgium)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Breast cancer; CD28; CD57; Cellular senescence; Chemotherapy; Immunosenescence

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; CD28 ANTIGEN; CD57 ANTIGEN;

ADULT; AGING; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSENESCENCE; LEUKOCYTE; LONGITUDINAL STUDY; MEDULLARY CARCINOMA; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SENESCENCE; T LYMPHOCYTE SUBPOPULATION; AGED; BREAST NEOPLASMS; CELL AGING; DRUG EFFECTS; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ANTIGENS, CD28; ANTIGENS, CD57; BREAST NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; DNA DAMAGE; FEMALE; HUMANS; MIDDLE AGED;

EID: 84924957319     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Goronzy JJ, Lee WW and Weyand CM: Aging and T-cell diversity. Exp Gerontol 42: 400-406, 2007.
2. Pawelec G, Larbi A and Derhovanessian E: Senescence of the human immune system. J Comp Pathol 142 Suppl 1: S39-44, 2010.
3. Franceschi C: Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev 65: S173-176, 2007.
4. Fulop T, Kotb R, Fortin CF, Pawelec G, de Angelis F and Larbi A: Potential role of immunosenescence in cancer development. Ann N Y Acad Sci 1197: 158-165, 2010.
5. Chen IH, Lai YL, Wu CL, Chang YF, Chu CC, Tsai IF, Sun FJ and Lu YT: Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection. Cancer Immunol Immunother 59: 323-334, 2010.
6. Falci C, Gianesin K, Sergi G, Giunco S, De Ronch I, Valpione S, Solda C, Fiduccia P, Lonardi S, Zanchetta M, Keppel S, Brunello A, Zafferri V, Manzato E, De Rossi A and Zagonel V: Immune senescence and cancer in elderly patients: results from an exploratory study. Exp Gerontol 48: 1436-1442, 2013.
7. Mozaffari F, Lindemalm C, Choudhury A, Granstam-Bjorneklett H, Lekander M, Nilsson B, Ojutkangas ML, Osterborg A, Bergkvist L and Mellstedt H: Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophospha-mide and/or radiotherapy in breast cancer: a longitudinal study. Cancer Immunol Immunother 58: 111-120, 2009.
8. Akbar AN and Henson SM: Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol 11: 289-295, 2011.
9. + T cells. Blood 101: 2711-2720, 2003.
10. Campisi J: Aging, cellular senescence and cancer. Annu Rev Physiol 75: 685-705, 2013.
11. Liu Y, Johnson SM, Fedoriw Y, Rogers AB, Yuan H, Krishnamurthy J and Sharpless NE: Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood 117: 3257-3267, 2011.
12. + T lymphocytes overexpressing telomerase. J Immunol 177: 3657-3668, 2006.
13. Onyema OO, Njemini R, Bautmans I, Renmans W, De Waele M and Mets T: Cellular aging and senescence characteristics of human T-lymphocytes. Biogerontology 13: 169-181, 2012.
14. Effros RB: Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev Comp Immunol 21: 471-478, 1997.
15. + T cells. Eur J Immunol 38: 995-1000, 2008.
16. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM and Goronzy JJ: T cell subset-specific susceptibility to aging. Clin Immunol 127: 107-118, 2008.
17. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101: 4260-4266, 2003.
18. + T-lymphocytes and their homing characteristics. Front Immunol Conference Abstract: 15th International Congress of Immuno-logy (ICI). 2013.
19. Ewald JA, Desotelle JA, Wilding G and Jarrard DF: Therapy-induced senescence in cancer. J Natl Cancer Inst 102: 1536-1546, 2010.
20. Gewirtz DA, Holt SE and Elmore LW: Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76: 947-957, 2008.
21. Dierick JF, Eliaers F, Remacle J, Raes M, Fey SJ, Larsen PM and Toussaint O: Stress-induced premature senescence and replicative senescence are different phenotypes, proteomic evidence. Biochem Pharmacol 64: 1011-1017, 2002.
22. Toussaint O, Royer V, Salmon M and Remacle J: Stress-induced premature senescence and tissue ageing. Biochem Pharmacol 64: 1007-1009, 2002.
23. Roninson IB: Tumor cell senescence in cancer treatment. Cancer Res 63: 2705-2715, 2003.
24. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL and Gress RE: Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84: 2221-2228, 1994.
25. Shakir DK and Rasul KI: Chemotherapy induced cardio-myopathy: pathogenesis, monitoring and management. J Clin Med Res 1: 8-12, 2009.
26. McCoy MJ, Lake RA, van der Most RG, Dick IM and Nowak AK: Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies. Br J Cancer 107: 1107-1115, 2012.
27. van der Most RG, Currie AJ, Cleaver AL, Salmons J, Nowak AK, Mahendran S, Larma I, Prosser A, Robinson BW, Smyth MJ, Scalzo AA, Degli-Esposti MA and Lake RA: Cyclo-phosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth. PLoS One 4: e6982, 2009.
28. Mendez-Lagares G, Garcia-Perganeda A, del Mar del Pozo-Balado M, Genebat M, Ruiz-Mateos E, Garcia Garcia M, Munoz-Fernandez MA, Pacheco YM and Leal M: Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration. J Antimicrob Chemother 67: 1228-1237, 2012.
29. + cells in young individuals. PLoS One 9: e88538, 2014.
30. + T cells in humans: a contribution to understand the relationship between inflam mation and immunosenescence. Exp Gerontol 38: 981-987, 2003.
31. Simpson RJ, Cosgrove C, Ingram LA, Florida-James GD, Whyte GP, Pircher H and Guy K: Senescent T-lymphocytes are mobilised into the peripheral blood compartment in young and older humans after exhaustive exercise. Brain Behav Immun 22: 544-551, 2008.
32. Simpson RJ, Florida-James GD, Cosgrove C, Whyte GP, Macrae S, Pircher H and Guy K: High-intensity exercise elicits the mobilization of senescent T lymphocytes into the peripheral blood compartment in human subjects. J Appl Physiol 103: 396-401, 2007.
33. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO and Ferguson F: Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37: 445-453, 2002.
34. Wikby A, Maxson P, Olsson J, Johansson B and Ferguson FG: Changes in CD8 and CD4 lymphocyte subsets, T cell proli-feration responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 102: 187-198, 1998.
35. Campbell JP, Guy K, Cosgrove C, Florida-James GD and Simpson RJ: Total lymphocyte CD8 expression is not a reliable marker of cytotoxic T-cell populations in human peripheral blood following an acute bout of high-intensity exercise. Brain Behav Immun 22: 375-380, 2008.
36. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO and Ferguson FG: Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121: 187-201, 2000.
37. +) T lympho-cytes in the peripheral blood of patients with advanced gastric cancer. Int J Clin Oncol 13: 528-535, 2008.
38. + T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 79: 3675-3683, 2005.
39. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA. 102: 9571-9576, 2005.
40. Poschke I, De Boniface J, Mao Y and Kiessling R: Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients. Int J Cancer 131: 1611-1620, 2012.
41. te Poele RH, Okorokov AL, Jardine L, Cummings J and Joel SP: DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876-1883, 2002.
42. + subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence. Immunology 106: 27-37, 2002.
43. Mozaffari F, Lindemalm C, Choudhury A, Granstam-Bjorneklett H, Helander I, Lekander M, Mikaelsson E, Nilsson B, Ojutkangas ML, Osterborg A, Bergkvist L and Mellstedt H: NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo-and radiotherapy. Br J Cancer 97: 105-111, 2007.
44. Plate JM, Plate AE, Shott S, Bograd S and Harris JE: Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas. Cancer Immunol Immunother 54: 915-925, 2005.
45. Newton K and Strasser A: Ionizing radiation and chemo-therapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy. J Exp Med 191: 195-200, 2000.
46. Stahnke K, Fulda S, Friesen C, Strauss G and Debatin KM: Activation of apoptosis pathways in peripheral blood lympho-cytes by in vivo chemotherapy. Blood 98: 3066-3073, 2001.
47. Hampel B, Wagner M, Teis D, Zwerschke W, Huber LA and Jansen-Durr P: Apoptosis resistance of senescent human fibro-blasts is correlated with the absence of nuclear IGFBP-3. Aging Cell 4: 325-330, 2005.
48. Wang E: Senescent human fibroblasts resist programmed cell death and failure to suppress bcl2 is involved. Cancer Res 55: 2284-2292, 1995.
49. Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P and Boulamatsis D: Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87: 21-27, 2002.
50. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8: 379-385, 2002.
51. + T cells, which are increased in active rheumatoid arthritis. Clin Immunol 124: 328-335, 2007.